Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daisy Alapat

Concepts (252)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
30
2025
3050
1.910
Why?
Flow Cytometry
5
2018
400
0.900
Why?
Immunoglobulins
2
2018
76
0.670
Why?
Plasma Cells
3
2025
239
0.650
Why?
Immunoglobulin kappa-Chains
2
2016
22
0.610
Why?
Bone Marrow
7
2022
363
0.560
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
125
0.560
Why?
DNA, Neoplasm
1
2018
146
0.550
Why?
Hematopoietic Stem Cell Transplantation
4
2024
606
0.520
Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
106
0.510
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
59
0.490
Why?
Immunoglobulin lambda-Chains
1
2015
15
0.480
Why?
Neoplasm, Residual
6
2025
173
0.480
Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.470
Why?
Receptors, Antigen, B-Cell
1
2015
7
0.470
Why?
Tumor Microenvironment
4
2024
255
0.440
Why?
Humans
50
2025
52593
0.390
Why?
Plasmacytoma
3
2022
43
0.380
Why?
Cell Differentiation
1
2015
673
0.370
Why?
Lymphoma, Mantle-Cell
1
2012
18
0.370
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
12
0.370
Why?
Carcinoembryonic Antigen
1
2011
13
0.350
Why?
Calcitonin
1
2011
30
0.350
Why?
Antigens, CD
1
2012
216
0.340
Why?
Middle Aged
20
2025
13096
0.320
Why?
Prognosis
9
2025
2118
0.320
Why?
Carcinoma
1
2011
137
0.320
Why?
Myogenin
1
2008
4
0.300
Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.300
Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.300
Why?
Paraproteinemias
2
2022
74
0.280
Why?
Gene Expression Profiling
4
2025
1110
0.280
Why?
Positron-Emission Tomography
3
2025
303
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1031
0.270
Why?
Neoplasms, Second Primary
2
2019
77
0.260
Why?
Aged
18
2025
10191
0.250
Why?
Female
23
2025
28262
0.240
Why?
Male
20
2025
26863
0.240
Why?
Treatment Outcome
10
2022
5486
0.230
Why?
Pancytopenia
3
2016
38
0.230
Why?
Diffusion Magnetic Resonance Imaging
1
2025
133
0.220
Why?
Gastrointestinal Neoplasms
1
2022
42
0.190
Why?
Embolization, Therapeutic
2
2021
88
0.190
Why?
Neoplasms, Plasma Cell
2
2020
37
0.180
Why?
Thrombocytopenia
1
2022
92
0.180
Why?
Cryosurgery
1
2021
36
0.180
Why?
Chromosome Deletion
2
2023
141
0.180
Why?
Skin Neoplasms
2
2016
500
0.170
Why?
Transplantation, Autologous
4
2024
488
0.160
Why?
Adult
11
2025
14170
0.160
Why?
Combined Modality Therapy
1
2021
639
0.160
Why?
Ploidies
1
2018
10
0.140
Why?
Phenotype
2
2025
800
0.140
Why?
Hematopoietic Stem Cells
1
2019
188
0.140
Why?
Leukemia, Myeloid, Acute
1
2019
203
0.140
Why?
Kidney Diseases
1
2020
231
0.140
Why?
Herpesvirus 8, Human
1
2019
98
0.140
Why?
Sarcoma, Myeloid
1
2017
20
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Immunohistochemistry
3
2016
984
0.130
Why?
Lymph Nodes
2
2019
252
0.130
Why?
Amyloidosis
2
2016
85
0.130
Why?
Cell Cycle
1
2018
240
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Disease Progression
4
2025
873
0.130
Why?
Registries
3
2025
629
0.130
Why?
Skin Diseases, Infectious
1
2016
7
0.130
Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.130
Why?
Anemia, Aplastic
1
2016
11
0.130
Why?
Myeloproliferative Disorders
1
2016
31
0.120
Why?
Electrophoresis, Capillary
1
2015
10
0.120
Why?
In Situ Hybridization
1
2015
68
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
V(D)J Recombination
1
2015
4
0.120
Why?
Immunophenotyping
1
2015
117
0.120
Why?
Diagnosis, Differential
3
2016
1048
0.120
Why?
RNA, Messenger
2
2015
1139
0.110
Why?
Fatal Outcome
1
2015
196
0.110
Why?
Bone Marrow Transplantation
2
2022
113
0.110
Why?
Immunoglobulin Light Chains
1
2015
90
0.110
Why?
Prealbumin
1
2014
22
0.110
Why?
Bone Marrow Neoplasms
1
2014
13
0.110
Why?
Neoplasm Proteins
1
2016
328
0.110
Why?
Aged, 80 and over
5
2025
3420
0.110
Why?
Polymerase Chain Reaction
1
2015
460
0.100
Why?
Hodgkin Disease
1
2014
49
0.100
Why?
Parvoviridae Infections
1
2013
20
0.100
Why?
Parvovirus B19, Human
1
2013
17
0.100
Why?
Partial Thromboplastin Time
1
2012
14
0.100
Why?
Prothrombin Time
1
2012
18
0.100
Why?
Retrospective Studies
5
2025
6671
0.100
Why?
Afibrinogenemia
1
2012
5
0.100
Why?
Cardiomyopathies
1
2014
124
0.100
Why?
Immunoglobulins, Intravenous
1
2013
63
0.100
Why?
Predictive Value of Tests
1
2015
952
0.100
Why?
Plasma Exchange
1
2012
25
0.100
Why?
Retroperitoneal Neoplasms
1
2012
18
0.100
Why?
Glycoproteins
1
2012
122
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
857
0.100
Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.090
Why?
Histoplasma
1
2011
24
0.090
Why?
Antigens, Fungal
1
2011
20
0.090
Why?
Longitudinal Studies
2
2024
747
0.090
Why?
Immunoenzyme Techniques
1
2011
136
0.090
Why?
Hepatitis C
1
2012
79
0.090
Why?
Histoplasmosis
1
2011
47
0.090
Why?
Carcinoma, Neuroendocrine
1
2011
25
0.090
Why?
In Situ Hybridization, Fluorescence
3
2023
263
0.090
Why?
Dose-Response Relationship, Drug
2
2016
1378
0.080
Why?
Splenic Neoplasms
1
2009
2
0.080
Why?
Gene Expression
1
2012
623
0.080
Why?
Thyroid Neoplasms
1
2011
116
0.080
Why?
Myelodysplastic Syndromes
1
2009
86
0.080
Why?
Mutagenesis, Site-Directed
1
2008
97
0.070
Why?
Hemangioma
1
2009
84
0.070
Why?
Tomography, X-Ray Computed
3
2023
1162
0.070
Why?
HIV Infections
1
2012
388
0.070
Why?
Survival Analysis
2
2021
673
0.070
Why?
Protein Processing, Post-Translational
1
2008
153
0.070
Why?
Cells, Cultured
2
2008
1588
0.070
Why?
Stem Cell Transplantation
2
2022
187
0.070
Why?
Graft vs Host Disease
1
2007
88
0.060
Why?
Adolescent
2
2025
6737
0.060
Why?
Muscle Proteins
1
2008
348
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
Why?
Semaphorin-3A
1
2004
2
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
95
0.060
Why?
Nerve Degeneration
1
2004
24
0.060
Why?
Acid Anhydride Hydrolases
1
2004
14
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
49
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
50
0.060
Why?
ROC Curve
1
2025
254
0.060
Why?
Antineoplastic Agents
1
2013
1221
0.060
Why?
Imidazoles
1
2005
124
0.060
Why?
Muscle, Smooth, Vascular
1
2005
136
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
115
0.050
Why?
Pyridines
1
2005
134
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
Pyrimidines
1
2005
200
0.050
Why?
Gene Expression Regulation
1
2008
1006
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Enzyme Inhibitors
1
2005
372
0.050
Why?
Adrenal Cortex Hormones
1
2023
114
0.050
Why?
Hippocampus
1
2004
201
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
96
0.050
Why?
Case-Control Studies
2
2019
1202
0.050
Why?
Transcriptome
1
2025
368
0.050
Why?
Cohort Studies
2
2020
1553
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Dexamethasone
1
2024
440
0.050
Why?
Mediastinum
1
2021
21
0.050
Why?
Gastrointestinal Tract
1
2022
108
0.050
Why?
Fever
1
2022
113
0.050
Why?
Neurons
1
2004
418
0.050
Why?
Vincristine
1
2021
88
0.040
Why?
T-Lymphocytes
1
2023
329
0.040
Why?
Axilla
1
2021
92
0.040
Why?
Prednisone
1
2021
102
0.040
Why?
Pelvis
1
2021
67
0.040
Why?
Time Factors
2
2017
3000
0.040
Why?
Cyclophosphamide
1
2021
172
0.040
Why?
Radiopharmaceuticals
1
2021
205
0.040
Why?
Alzheimer Disease
1
2004
331
0.040
Why?
Signal Transduction
2
2004
1714
0.040
Why?
Fluorodeoxyglucose F18
1
2021
188
0.040
Why?
Tumor Burden
1
2020
136
0.040
Why?
Mice
3
2023
5958
0.040
Why?
Doxorubicin
1
2021
241
0.040
Why?
Antibodies, Monoclonal
1
2023
478
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
Hospitalization
1
2024
749
0.040
Why?
Cell Line, Tumor
1
2023
1436
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Epstein-Barr Virus Infections
1
2019
33
0.040
Why?
Phosphorylation
3
2005
530
0.040
Why?
Herpesviridae Infections
1
2019
57
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
138
0.040
Why?
Virus Diseases
1
2019
46
0.040
Why?
Follow-Up Studies
1
2024
2291
0.040
Why?
Neoplasm Recurrence, Local
1
2022
643
0.030
Why?
Liver
1
2022
1160
0.030
Why?
Scleromyxedema
1
2016
4
0.030
Why?
Schnitzler Syndrome
1
2016
4
0.030
Why?
Cryoglobulinemia
1
2016
13
0.030
Why?
Xanthomatosis
1
2016
10
0.030
Why?
Asymptomatic Diseases
1
2016
38
0.030
Why?
POEMS Syndrome
1
2016
34
0.030
Why?
Melphalan
1
2016
181
0.030
Why?
Disease-Free Survival
1
2016
464
0.030
Why?
Young Adult
1
2025
4337
0.030
Why?
Animals
3
2023
13507
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
186
0.030
Why?
Reed-Sternberg Cells
1
2014
2
0.030
Why?
HIV Seronegativity
1
2014
3
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Thalidomide
1
2016
378
0.030
Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
Why?
Cell Division
2
2005
288
0.030
Why?
Heterozygote
1
2014
91
0.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
45
0.030
Why?
Mutation
1
2019
1344
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
582
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
412
0.030
Why?
Remission Induction
1
2014
219
0.030
Why?
Fibrinogen
1
2012
34
0.030
Why?
Blood Coagulation
1
2012
62
0.020
Why?
Risk Assessment
1
2017
1350
0.020
Why?
Survival Rate
1
2015
952
0.020
Why?
Neoplasm Staging
1
2015
768
0.020
Why?
Reference Values
1
2012
313
0.020
Why?
Biopsy
1
2014
607
0.020
Why?
Antibodies, Fungal
1
2011
2
0.020
Why?
Mycological Typing Techniques
1
2011
3
0.020
Why?
Cross Reactions
1
2011
41
0.020
Why?
Lung Diseases, Fungal
1
2011
20
0.020
Why?
Immunocompromised Host
1
2011
123
0.020
Why?
Splenectomy
1
2009
36
0.020
Why?
Severity of Illness Index
1
2012
1037
0.020
Why?
Sensitivity and Specificity
1
2011
883
0.020
Why?
Blood Transfusion
1
2009
129
0.020
Why?
Transplantation, Isogeneic
1
2007
2
0.020
Why?
Laparoscopy
1
2009
181
0.020
Why?
Mice, Inbred C3H
1
2007
82
0.020
Why?
Cyclosporine
1
2007
67
0.020
Why?
Mice, SCID
1
2007
182
0.020
Why?
Magnetic Resonance Imaging
1
2014
1545
0.020
Why?
Models, Animal
1
2007
228
0.020
Why?
Immunosuppressive Agents
1
2007
250
0.010
Why?
Macromolecular Substances
1
2004
33
0.010
Why?
Physical Chromosome Mapping
1
2004
7
0.010
Why?
tau Proteins
1
2004
25
0.010
Why?
Genetic Complementation Test
1
2004
46
0.010
Why?
Epitopes
1
2004
62
0.010
Why?
Epidermal Growth Factor
1
2004
37
0.010
Why?
Microtubule-Associated Proteins
1
2004
64
0.010
Why?
Catalytic Domain
1
2004
61
0.010
Why?
Cricetulus
1
2004
104
0.010
Why?
Mutagenesis
1
2004
60
0.010
Why?
Cloning, Molecular
1
2004
182
0.010
Why?
Cricetinae
1
2004
193
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2004
107
0.010
Why?
Receptors, Cell Surface
1
2004
113
0.010
Why?
RNA
1
2004
172
0.010
Why?
Cell Survival
1
2005
602
0.010
Why?
Amino Acid Sequence
1
2004
574
0.010
Why?
Molecular Sequence Data
1
2004
773
0.010
Why?
Nerve Tissue Proteins
1
2004
192
0.010
Why?
Mice, Inbred C57BL
1
2007
1900
0.010
Why?
Cell Line
1
2004
1033
0.010
Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description